Evaluation of UGT1A1 genotyping for predicting individual toxicity of irinotecan plus platinum analog regimens: Interim safety analysis of a prospective observational study.
Masashi Takano
Consultant or Advisory Role - Daiichi Sankyo (U)
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Kaichiro Yamamoto
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Tsutomu Tabata
Research Funding - Daiichi Sankyo
Yuji Minegishi
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Takuma Yokoyama
Research Funding - Daiichi Sankyo
Eiji Hirata
Research Funding - Daiichi Sankyo
Takeshi Ikeda
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Junzo Kigawa
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Kouzo Yamada
Research Funding - Daiichi Sankyo
Satoshi Morita
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yuichi Ando
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Other Remuneration - Daiichi Sankyo
Yukihiro Okutani
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Masahiro Sugihara
Employment or Leadership Position - Daiichi Sankyo
Toru Sugiyama
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Yasuo Ohashi
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Yuh Sakata
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo